Co-Morbidity of Infectious and Addictive Diseases in St. Petersburg and the Leningrad Region, RussiaKrupitsky E.M.a · Zvartau E.E.a · Lioznov D.A.a · Tsoy M.V.a · Egorova V.Y.a · Belyaeva T.V.a · Antonova T.V.a · Brazhenko N.A.a · Zagdyn Z.M.a · Verbitskaya E.V.a · Zorina Y.a · Karandashova G.F.a · Slavina T.Y.a · Grinenko A.Y.a · Samet J.H.b · Woody G.E.c
aScientific Research Center of Addiction and Psychopharmacology, St. Petersburg State Pavlov Medical University, St. Petersburg, Russia; bDepartment of Medicine, School of Medicine, Boston University, Boston, Mass., and cDepartment of Psychiatry, School of Medicine, University of Pennsylvania, Philadelphia, Pa., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
The Russian health care system is organized around specific diseases, with relatively little focus on integration across specialties to address co-morbidities. This organizational structure presents new challenges in the context of the recent epidemics of injection drug use (IDU) and HIV. This paper uses existing and new data to examine the prevalence of reported new cases of drug dependence (heroin) and HIV over time as well as associations between drug dependence and alcoholism, hepatitis B and C, and tuberculosis in the City of St. Petersburg and the Leningrad region. We found a sharp rise in reported cases of IDU beginning in 1991 and continuing until 2002/2003, followed by a sharp rise in newly reported cases of HIV. These rises were followed by a drop in new cases of HIV and drug addiction in 2002/2003 and a drop in the proportion of HIV-positve individuals with IDU as a risk factor. Infection with hepatitis B and C were common, especially among injection drug users (38 and 85%, respectively), but also in alcoholics (7 and 14%). Tuberculosis was more common in alcoholics (53%) than in persons with alcoholism and drug dependence (10%), or with drug dependence alone (4%). Though these data have many limitations, they clearly demonstrate that drug dependence and/or alcoholism, HIV, hepatitis, and tuberculosis frequently co-occur in St. Petersburg and the Leningrad Region. Prevention and treatment services across medical specialties should be integrated to address the wide range of issues that are associated with these co-morbidities.
© 2006 S. Karger AG, Basel
Adelekan M: Reviewing the evidence of IDU epidemics. Proceedings of the Global Research Network on HIV Prevention in Drug-Using Populations: HIV and Drug Use. The Global Situation. Bethesda: National Institute on Drug Abuse, 2003, pp 12–20.
- Dehne KL, Grund JP, Khodakevich Y, Kobyshcha Y: The HIV/AIDS epidemic among drug injectors in Eastern Europe: Patterns, trends and determinants. J Drug Issues 1999;29:729–776.
Federal AIDS Centre of Russia: HIV Infection. Information Bulletin No. 20. Moscow: Federal AIDS Centre of Russia, 2001 (in Russian).
- Grassly NC, Lowndes CM, Rhodens T, et al: Modeling emerging HIV epidemics: The role of injection drug use and sexual transmission in the Russian Federation, China, and India. Int J Drug Policy 2003;14:25–43.
- Garfein R, Vlahov D, Galai N, et al: Viral infections in short-term drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996;86:655–661.
Farmer PE, Kononets AS, Borisov SE, Goldfarb A, Healing T, McKee M: Recrudescent tuberculosis in the Russian Federation. Global Impact of Tuberculosis. Cambridge, MA: Harvard Medical School/Open Society Institute, 1999, pp 41–83.
- Krupitsky E, Zvartau E, Karandashova G, Horton NJ, Schoolwerth KR, Bryant K, Samet JH: The onset of HIV infection in the Leningrad Region of Russia: A focus on drug and alcohol dependence. HIV Med 2004;5:30–33.
- Herrera JL: Serological diagnosis of viral hepatitis. S Med J 1994;87:677–684.
Allen JP (ed): Assessing Alcohol Problems: A Guide for Clinicians and Researchers. Bethesda, NIAAA, 1995.
- McLellan AT, Luborsky L, Woody GE, O’Brien CP: An improved diagnostic evaluation instrument for substance abuse patients: The Addiction Severity Index. J Nerv Ment Dis 1980;168:26–33.
Sobell LC, Sobell MB: Timeline follow-back: A technique for assessing self-reported alcohol consumption; in Litten R, Allen J (eds): Measuring Alcohol Consumption. Totowa, Human Press, 1992, pp 41–72.
Krupitsky E, Zvartau EE, Lioznov D, Horton NJ, Williams ES, Samet JH: Alcohol use and HIV risk-behaviors among HIV-infected inpatients in St. Petersburg, Russia. Alcohol Clin Exp Res 2003;27(suppl):69.
- Cohn JA: HIV-1 infection in injection drug users. Infect Dis Clin North Am 2002;16:745–770.
Sorensen JL, Mason CL, Perlman DC: HIV/hepatitis prevention in drug abuse treatment programs. Science and Practice Perspectives, NIDA 2002;1:4–12.
Fedotova TT, Zemerov VB, Efimova OS: Development of HIV infection epidemic among intravenous drug users in the Sverdlovsky region (in Russian). Zhurnal Mikrobiol EpidemiolImmunobiol 2003:86–89.
- Ball A, Stimson GV, Kobyshcha Y, Fitch C, Pokrovsky V: HIV infection associated with drug injecting in the newly independent states, Eastern Europe: The social and economic context of epidemics. Addiction 1999;94:1323–1336.
Cooper ML: Alcohol use and risky sexual behavior among college students and youth: Evaluating the evidence. J Stud Alcohol Suppl 2002;(14):101–117.
- Scheidt DM: HIV risk behavior among alcoholic inpatients before and after treatment. Addict Behav 1999;24:725–730.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.